Aurigene, Agios in cancer deal

Aurigene Discovery Technologies Ltd. (Bangalore, India) granted Agios Pharmaceuticals Inc. (NASDAQ:AGIO) exclusive, worldwide rights to a portfolio of small molecules against an undisclosed cancer metabolism target. Aurigene is a subsidiary of Dr. Reddy's Laboratories Ltd. (NYSE:RDY)...